1. Home
  2. ABEO vs PCYO Comparison

ABEO vs PCYO Comparison

Compare ABEO & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • PCYO
  • Stock Information
  • Founded
  • ABEO N/A
  • PCYO 1976
  • Country
  • ABEO United States
  • PCYO United States
  • Employees
  • ABEO N/A
  • PCYO N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • PCYO Water Supply
  • Sector
  • ABEO Health Care
  • PCYO Utilities
  • Exchange
  • ABEO Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • ABEO 243.9M
  • PCYO 254.1M
  • IPO Year
  • ABEO 1980
  • PCYO N/A
  • Fundamental
  • Price
  • ABEO $6.58
  • PCYO $10.65
  • Analyst Decision
  • ABEO Strong Buy
  • PCYO
  • Analyst Count
  • ABEO 3
  • PCYO 0
  • Target Price
  • ABEO $18.00
  • PCYO N/A
  • AVG Volume (30 Days)
  • ABEO 273.8K
  • PCYO 41.4K
  • Earning Date
  • ABEO 11-11-2024
  • PCYO 11-13-2024
  • Dividend Yield
  • ABEO N/A
  • PCYO N/A
  • EPS Growth
  • ABEO N/A
  • PCYO N/A
  • EPS
  • ABEO N/A
  • PCYO 0.25
  • Revenue
  • ABEO N/A
  • PCYO $19,555,000.00
  • Revenue This Year
  • ABEO N/A
  • PCYO N/A
  • Revenue Next Year
  • ABEO $7,097.06
  • PCYO N/A
  • P/E Ratio
  • ABEO N/A
  • PCYO $42.63
  • Revenue Growth
  • ABEO 147.52
  • PCYO N/A
  • 52 Week Low
  • ABEO $3.05
  • PCYO $8.94
  • 52 Week High
  • ABEO $9.01
  • PCYO $11.32
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 70.20
  • PCYO 50.44
  • Support Level
  • ABEO $6.39
  • PCYO $10.48
  • Resistance Level
  • ABEO $6.74
  • PCYO $10.86
  • Average True Range (ATR)
  • ABEO 0.32
  • PCYO 0.23
  • MACD
  • ABEO 0.05
  • PCYO -0.03
  • Stochastic Oscillator
  • ABEO 90.48
  • PCYO 27.48

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: